Protein conjugate vaccines – how much is enough?
- 1 August 2001
- journal article
- other
- Published by Elsevier in Trends in Microbiology
- Vol. 9 (8) , 364-365
- https://doi.org/10.1016/s0966-842x(01)02076-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK ToddlersThe Journal of Infectious Diseases, 2001
- Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infantsThe Pediatric Infectious Disease Journal, 2000
- Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccineThe Lancet, 1999
- The Induction of Immunologic Memory after Vaccination withHaemophilus influenzaeType b Conjugate and Acellular Pertussis–Containing Diphtheria, Tetanus, and Pertussis Vaccine CombinationThe Journal of Infectious Diseases, 1999
- Recent developments in bacterial conjugate vaccinesJournal of Medical Microbiology, 1998
- Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without boosterThe Lancet, 1997
- Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccineThe Lancet, 1996
- Child Mortality Following Standard, Medium or High Titre Measles Immunization in West AfricaInternational Journal of Epidemiology, 1996
- The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae type bThe Journal of Infectious Diseases, 1984
- The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type bThe Journal of Infectious Diseases, 1983